Transparency Life Sciences (TLS) is pioneering the concept of an all-digital clinical development services company. Rapid advances in digital technology and strong regulatory support have created the opportunity for TLS to catalyze a fundamental transformation in clinical trial design and execution, significantly to improve the quality of clinical trials while reducing their overall cost. TLS's approach combines crowdsourcing and mobile health technology to advance drug candidates through clinical trials with unprecedented efficiency and patient and regulatory relevance. The use of digital technology allows TLS to reduce or eliminate reliance on physical study sites that are expensive, complex and inconvenient for patients, and also limit the geographic scope of enrollment
